ACTG Publications

TitleAuthorsDateJournalIssueVolume
Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results.Sax, Paul E ; Tierney, Camlin ; Collier, Ann C ; Daar, Eric S ; Mollan, Katie ; Budhathoki, Chakra ; Godfrey, Catherine ; Jahed, Nasreen C ; Myers, Laurie ; Katzenstein, David ; Farajallah, Awny ; Rooney, James F ; Ha, Belinda ; Woodward, William C ; Feinberg, Judith ; Tashima, Karen ; Murphy, Robert L ; Fischl, Margaret A ; AIDS Clinical 2011 Oct 15J Infect Dis8204
Abacavir-lamivudine versus tenofovir-emtricitabine for initial HIV-1 therapy.Sax, Paul E ; Tierney, Camlin ; Collier, Ann C ; Fischl, Margaret A ; Mollan, Katie ; Peeples, Lynne ; Godfrey, Catherine ; Jahed, Nasreen C ; Myers, Laurie ; Katzenstein, David ; Farajallah, Awny ; Rooney, James F ; Ha, Belinda ; Woodward, William C ; Koletar, Susan L ; Johnson, Victoria A ; Geiseler, P Jan ; Daar, Eric S ; AIDS Clinical 2009 Dec 3N Engl J Med23361
Antiretroviral therapy and efficacy after virologic failure on first-line boosted protease inhibitor regimens.Zheng, Yu ; Hughes, Michael D ; Lockman, Shahin ; Benson, Constance A ; Hosseinipour, Mina C ; Campbell, Thomas B ; Gulick, Roy M ; Daar, Eric S ; Sax, Paul E ; Riddler, Sharon A ; Haubrich, Richard ; Salata, Robert A ; Currier, Judith S2014 Sep 15Clin Infect Dis659
Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data.Mollan, Katie R ; Smurzynski, Marlene ; Eron, Joseph J ; Daar, Eric S ; Campbell, Thomas B ; Sax, Paul E ; Gulick, Roy M ; Na, Lumine ; O'Keefe, Lauren ; Robertson, Kevin R ; Tierney, Camlin2014 Jul 1Ann Intern Med1161
Associations of inflammatory markers with AIDS and non-AIDS clinical events after initiation of antiretroviral therapy: AIDS clinical trials group A5224s, a substudy of ACTG A5202.McComsey, Grace A ; Kitch, Douglas ; Sax, Paul E ; Tierney, Camlin ; Jahed, Nasreen C ; Melbourne, Kathleen ; Ha, Belinda ; Brown, Todd T ; Bloom, Anthony ; Fedarko, Neal ; Daar, Eric S2014 Feb 1J Acquir Immune Defic Syndr265
Atazanavir plus ritonavir or efavirenz as part of a 3-drug regimen for initial treatment of HIV-1.Daar, Eric S ; Tierney, Camlin ; Fischl, Margaret A ; Sax, Paul E ; Mollan, Katie ; Budhathoki, Chakra ; Godfrey, Catherine ; Jahed, Nasreen C ; Myers, Laurie ; Katzenstein, David ; Farajallah, Awny ; Rooney, James F ; Pappa, Keith A ; Woodward, William C ; Patterson, Kristine ; Bolivar, Hector ; Benson, Constance A ; Collier, Ann C ; AIDS2011 Apr 5Ann Intern Med7154
Blood (1->3)-beta-D-glucan as a diagnostic test for HIV-related Pneumocystis jirovecii pneumonia.Sax, Paul E ; Komarow, Lauren ; Finkelman, Malcolm A ; Grant, Philip M ; Andersen, Janet ; Scully, Eileen ; Powderly, William G ; Zolopa, Andrew R ; AIDS Clinical Trials Group Study A5164 Team2011 Jul 15Clin Infect Dis253
Bone mineral density and fractures in antiretroviral-naive persons randomized to receive abacavir-lamivudine or tenofovir disoproxil fumarate-emtricitabine along with efavirenz or atazanavir-ritonavir: Aids Clinical Trials Group A5224s, a substudy of ACTGMcComsey, Grace A ; Kitch, Douglas ; Daar, Eric S ; Tierney, Camlin ; Jahed, Nasreen C ; Tebas, Pablo ; Myers, Laurie ; Melbourne, Kathleen ; Ha, Belinda ; Sax, Paul E2011 Jun 15J Infect Dis12203
Changes in fat mitochondrial DNA and function in subjects randomized to abacavir-lamivudine or tenofovir DF-emtricitabine with atazanavir-ritonavir or efavirenz: AIDS Clinical Trials Group study A5224s, substudy of A5202.McComsey, Grace A ; Daar, Eric S ; O'Riordan, MaryAnn ; Collier, Ann C ; Kosmiski, Lisa ; Santana, Jorge L ; Fichtenbaum, Carl J ; Fink, Heidi ; Sax, Paul E ; Libutti, Daniel E ; Gerschenson, Mariana2013 Feb 15J Infect Dis4207
Changes in proteinuria and albuminuria with initiation of antiretroviral therapy: data from a randomized trial comparing tenofovir disoproxil fumarate/emtricitabine versus abacavir/lamivudine.Wyatt, Christina M ; Kitch, Douglas ; Gupta, Samir K ; Tierney, Camlin ; Daar, Eric S ; Sax, Paul E ; Ha, Belinda ; Melbourne, Kathleen ; McComsey, Grace A ; AIDS Clinical Trials Group Study A5224s Team2014 Sep 1J Acquir Immune Defic Syndr167
The Cost-effectiveness and Budget Impact of 2-Drug Dolutegravir-Lamivudine Regimens for the Treatment of HIV Infection in the United States.Girouard, Michael P ; Sax, Paul E ; Parker, Robert A ; Taiwo, Babafemi ; Freedberg, Kenneth A ; Gulick, Roy M ; Weinstein, Milton C ; Paltiel, A David ; Walensky, Rochelle P2016 Mar 15Clin Infect Dis662
Cost-effectiveness of adding an agent that improves immune responses to initial antiretroviral therapy (ART) in HIV-infected patients: guidance for drug development.Morris, Bethany L ; Scott, Callie A ; Wilkin, Timothy J ; Sax, Paul E ; Gulick, Roy M ; Freedberg, Kenneth A ; Schackman, Bruce R2012 Jan-FebHIV Clin Trials113
Cystatin C-based renal function changes after antiretroviral initiation: a substudy of a randomized trial.Gupta, Samir K ; Kitch, Douglas ; Tierney, Camlin ; Daar, Eric S ; Sax, Paul E ; Melbourne, Kathleen ; Ha, Belinda ; McComsey, Grace A ; AIDS Clinical Trials Group Study A5224s Team2014 MarOpen Forum Infect Dis11
Early antiretroviral therapy for patients with acute aids-related opportunistic infections: a cost-effectiveness analysis of ACTG A5164.Sax, Paul E ; Sloan, Caroline E ; Schackman, Bruce R ; Grant, Philip M ; Rong, Jian ; Zolopa, Andrew R ; Powderly, William ; Losina, Elena ; Freedberg, Kenneth A ; Cepac US And Actg A5164 Investigators2010 Sep-OctHIV Clin Trials511
Early virologic response to abacavir/lamivudine and tenofovir/emtricitabine during ACTG A5202.Grant, Philip M ; Tierney, Camlin ; Budhathoki, Chakra ; Daar, Eric S ; Sax, Paul E ; Collier, Ann C ; Fischl, Margaret A ; Zolopa, Andrew R ; Balamane, Maya ; Katzenstein, David2013 Nov-DecHIV Clin Trials614
HIV-1 amino acid changes among participants with virologic failure: associations with first-line efavirenz or atazanavir plus ritonavir and disease status.Mollan, Katie ; Daar, Eric S ; Sax, Paul E ; Balamane, Maya ; Collier, Ann C ; Fischl, Margaret A ; Lalama, Christina M ; Bosch, Ronald J ; Tierney, Camlin ; Katzenstein, David ; AIDS Clinical Trials Group Study A5202 Team2012 Dec 15J Infect Dis12206
Impact of randomized antiretroviral therapy initiation on glucose metabolism.Erlandson, Kristine Mace ; Kitch, Douglas ; Tierney, Camlin ; Sax, Paul E ; Daar, Eric S ; Melbourne, Kathleen M ; Ha, Belinda ; McComsey, Grace A2014 Jun 19AIDS1028
Impact of UGT1A1 Gilbert variant on discontinuation of ritonavir-boosted atazanavir in AIDS Clinical Trials Group Study A5202.Ribaudo, Heather J ; Daar, Eric S ; Tierney, Camlin ; Morse, Gene D ; Mollan, Katie ; Sax, Paul E ; Fischl, Margaret A ; Collier, Ann C ; Haas, David W ; DS Clinical Trials Group2013 Feb 1J Infect Dis3207
Inflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavir.McComsey, Grace A ; Kitch, Douglas ; Daar, Eric S ; Tierney, Camlin ; Jahed, Nasreen C ; Melbourne, Kathleen ; Ha, Belinda ; Brown, Todd T ; Bloom, Anthony ; Fedarko, Neal ; Sax, Paul E2012 Jul 17AIDS1126
The major genetic determinants of HIV-1 control affect HLA class I peptide presentation.International HIV Controllers Study ; Pereyra, Florencia ; Jia, Xiaoming ; McLaren, Paul J ; Telenti, Amalio ; DE Bakker, Paul I W ; Walker, Bruce D ; Ripke, Stephan ; Brumme, Chanson J ; Pulit, Sara L ; Carrington, Mary ; Kadie, Carl M ; Carlson, Jonathan M ; Heckerman, David ; Graham, Robert R ; Plenge, Robert M ; Deeks, Steven G ; Giann2010 Dec 10Science6010330
Peripheral and central fat changes in subjects randomized to abacavir-lamivudine or tenofovir-emtricitabine with atazanavir-ritonavir or efavirenz: ACTG Study A5224s.McComsey, Grace A ; Kitch, Douglas ; Sax, Paul E ; Tebas, Pablo ; Tierney, Camlin ; Jahed, Nasreen C ; Myers, Laurie ; Melbourne, Kathleen ; Ha, Belinda ; Daar, Eric S2011 Jul 15Clin Infect Dis253
Potential risks and benefits of HIV treatment simplification: a simulation model of a proposed clinical trial.Schackman, Bruce R ; Scott, Callie A ; Sax, Paul E ; Losina, Elena ; Wilkin, Timothy J ; McKinnon, John E ; Swindells, Susan ; Weinstein, Milton C ; Freedberg, Kenneth A2007 Oct 15Clin Infect Dis845
Reductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation: ACTG A5224s.Longenecker, Chris T ; Kitch, Douglas ; Sax, Paul E ; Daar, Eric S ; Tierney, Camlin ; Gupta, Samir K ; McComsey, Grace A ; AIDS Clinical Trials Group Study A5224s Team2015 Jun 1J Acquir Immune Defic Syndr269
Safety and immunogenicity of therapeutic DNA vaccination in individuals treated with antiretroviral therapy during acute/early HIV-1 infection.Rosenberg, Eric S ; Graham, Barney S ; Chan, Ellen S ; Bosch, Ronald J ; Stocker, Vicki ; Maenza, Janine ; Markowitz, Martin ; Little, Susan ; Sax, Paul E ; Collier, Ann C ; Nabel, Gary ; Saindon, Suzanne ; Flynn, Theresa ; Kuritzkes, Daniel ; Barouch, Dan H ; AIDS Clinical Trials Group A5187 Team2010PLoS One55
Sex differences in atazanavir pharmacokinetics and associations with time to clinical events: AIDS Clinical Trials Group Study A5202.Venuto, Charles S ; Mollan, Katie ; Ma, Qing ; Daar, Eric S ; Sax, Paul E ; Fischl, Margaret ; Collier, Ann C ; Smith, Kimberly Y ; Tierney, Camlin ; Morse, Gene D2014 DecJ Antimicrob Chemother1269
Test performance of blood beta-glucan for Pneumocystis jirovecii pneumonia in patients with AIDS and respiratory symptoms.Wood, Brian R ; Komarow, Lauren ; Zolopa, Andrew R ; Finkelman, Malcolm A ; Powderly, William G ; Sax, Paul E2013 Mar 27AIDS627
Weight and lean body mass change with antiretroviral initiation and impact on bone mineral density.Erlandson, Kristine M ; Kitch, Douglas ; Tierney, Camlin ; Sax, Paul E ; Daar, Eric S ; Tebas, Pablo ; Melbourne, Kathleen ; Ha, Belinda ; Jahed, Nasreen C ; McComsey, Grace A2013 Aug 24AIDS1327